An optimization of protocol for mixed chimerism induction in mice model

Folia Histochemica et Cytobiologica

Volumn 47, Issue 3, 2009, Pages 395-400

  Baskiewicz Masiuk M ^a   Grymula K ^a   Pius, E ^a   Halasa M ^a   Dziedziejko, V ^a   Schmidt, Ch ^a   Walczak, M ^a   Machalinski B ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

CD3e CD8a cells; Ly 49D NK1.1 cells; Mixed chimerism; TBI

Indexed keywords

ANTIBIOTIC AGENT; CD3 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CD45 ANTIGEN; CYCLOPHOSPHAMIDE; MONOCLONAL ANTIBODY CD8ALPHA; MONOCLONAL ANTIBODY NK1.1; RECOMBINANT ANTIBODY; T LYMPHOCYTE ANTIBODY; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BAGG ALBINO MOUSE; BLOOD CELL; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHIMERA; DRUG SAFETY; FLOW CYTOMETRY; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; PROCESS OPTIMIZATION; RADIATION DOSE; WHOLE BODY RADIATION;

ANIMALIA; MUS;

EID: 77149148453     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0086-z     Document Type: Article

References (21)

1. Golshayan D, Buhler L, Lechler RI, Pascual M. From current immunosuppressive strategies to clinical tolerance of allografts: Transpl Int. 2007;20:12-24.
2. Pree I, Pilat N, Wekerle T. Recent Progress in Tolerance Induction through Mixed Chimerism. Int Arch Allergy Immunol. 2007;144:254-266.
3. Golshayan D, Pascual M. Tolerance-Inducing Immunosuppressive Strategies in Clinical Transplantation. Drugs. 2008;68:2113-2130.
4. Ito H, Takeuchi Y, Shaffer J, Sykes M. Anti-CD40L Monoclonal Antibodies Can Replace Anti-CD4 Monoclonal Antibodies for the Nonmyeloablative Induction of Mixed Xenogeneic Chimerism. Transplantation. 2006;82:251-257.
5. + Cells. Am J Transplant. 2001;1:339-349.
6. Luo B, Nanji SA, Schur CD et al. Robust Tolerance to Fully Allogeneic Islet Transplants Achieved by Chimerism with Minimal Conditioning. Transplantation. 2005;80:370-377.
7. Westerhuis G, Maas WGE, Willemze R, Toes REM, Fibbe WE. Long-term mixed chimerism after immunological conditioning and MHC-mismatched stem cell transplantation is dependent on NK cell tolerance. Blood. 2005;106:2215-2220.
8. Baśekiewicz-Masiuk M, Grymuła K, Hałasa M, Pius E, Boehlke M, Machaliński B. Induction of mixed chimerism in mice by employing different conditioning protocols and bone marrow cell transplantation. Transplant Proc. 2009;41:1894-1899.
9. Halasa M, Baskiewicz-Masiuk M, Dabkowska E, Machalinski B. An efficient two-step metod to purify very small embryonic-like (VSEL) stem cells from umbilical cord blond (UCB). Folia Histochem Cytobiol. 2008;46:239-244.
10. Baumert B, Grymula K, Pietruszka D, et al. An optimization of hematopoietic stem and progenitor cell isolation for scientific and clinical purposes by the application of a new parameter determining the hematopoietic graft efficacy. Folia Histochem Cytobiol. 2008; 46:299-305.
11. Fehr T, Sykes M. Clinical experience with mixed chimerism to induce transplantation tolerance. Transpl Int. 2008;21:1118-1135.
12. Colson YL, Lange J, Fowler K, Ildstad ST. Mechanism for Cotolerance in Nonlethally Conditioned Mixed Chimeras: Negative Selection of the Vβ T-Cell Receptor Repertoire by Both Host and Donor Bone Marrow-Derived Cells. Blood. 1996;88:4601-4610.
13. Murakami M, Ito H, Harada E, Enoki T, Sykes M, Hamano K. Long-Term Survival of Xenogeneic Heart Grafts Achieved by Costimulatory Blockade and Transient Mixed Chimerism. Transplantation. 2006;82:275-281.
14. Kurtz J, Shaffer J, Lie A, Anosova N, Benichou G, Sykes M. Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells. Transplantation. 2004;103:4336-4342.
15. Takeuchi Y, Ito H, Kurtz J, Wekerle T, Ho L, Sykes M. Earlier Low-Dose TBI or DST Overcomes CD8+ T-Cell-Mediated Alloresistance to Allogeneic Marrow in Recipients of Anti-CD40L. Am J Transplant. 2004;4:31-40.
16. Koyama I, Nadazdin O, Boskovic S et al. Depletion of CD8 memory T cells for induction of tolerance previously transplanted kidney allograft. Am J Transplant. 2007;7:1055-1061.
17. Shimizu I, Tomita Y, Okano S et al. Efficacy and Limitation of Natural Killer Cell Depletion in Cyclophosphamide-Induced Tolerance. Surg Today. 2007;37:24-29.
18. Cho SG, Shuto Y, Soda Y et al. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation. Exp Hematol. 2004;32:1246-1254.
19. Kean LS, Hamby K, Koehn B et al. NK Cells Mediate Costimulation Blockade-Resistant Rejection of Allogeneic Stem Cells During Nonmyeloablative Transplantation. Am J Transplant. 2005;6:292-304.
20. Sogawa H, Boskovic S, Nadazdin O et al. Limited Efficacy and Unacceptable Toxicity of Cyclophosphamide fort he Induction of Mixed Chimerism and Renal Allograft Tolerance in Cynomolgus Monkeys. Transplantation. 2008;86:615-619.
21. Iwai T, Tomita Y, Shimizu I et al. The immunoregulatory roles of natural killer T cells in cyclophosphamide-induced tolerance. Transplantation. 2007;84:1686-1695.